Eversept Partners’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,325,591	Closed	-$6.67M	–	81
2024 Q1	$6.67M	Sell	2,325,591 -1,455,123	-38%	-$4.18M	0.45%	40
2023 Q4	$6.69M	Buy	3,780,714 +2,074,940	+122%	+$3.67M	0.59%	32
2023 Q3	$5.39M	Buy	+1,705,774	New	+$5.39M	0.46%	33